Extinction Learning in Adults With Tourette Syndrome

NCT04498364 — Not applicable, Completed, 10 participants, Johns Hopkins University

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Registry	NCT04498364
Status	Completed
Phase	Not applicable
Study type	Interventional; na, single group, masking: none, treatment
Enrollment	10 (Actual)
Sponsor	Johns Hopkins University (Other)
Conditions	Tourette Syndrome, Habit Reversal Training, Tic Disorders, Tics, Comprehensive Behavioral Intervention for Tics
Interventions	Habit Reversal Training (Behavioral)
Dates	start 2020-09-18, primary completion 2023-09-22, completion 2023-10-17, first posted 2020-08-04, last updated 2023-10-23
Locations	1 site in United States

-Summary

Aversive sensory phenomena such as premonitory urges play a central role in the behavioral treatment model of tics. Extinction learning and extinction recall are learning processes implicated within this model, but are still understudied for individuals with Tourette syndrome (TS). This study examines extinction learning and extinction recall in adults with TS using an experimental task. This study will also explore the relationship between extinction processes (i.e., extinction learning and extinction recall) and treatment outcomes with behavior therapy. Findings from this investigation will be used to update the behavioral treatment model, which serves as the basis for evidence-based behavioral interventions.

Expand all sections · Collapse all

+Arms and interventions

Arm	Type	Interventions	Description
Habit Reversal Training	Experimental	Behavioral: Habit Reversal Training	Habit Reversal Training (HRT) is a multi-component evidence-based treatment for tics. It will be delivered over 8 hours of treatment.

Habit Reversal Training (Behavioral): Habit Reversal Training (HRT) is a multi-component evidence-based treatment for tics.

+Outcome measures

Primary outcomes

Tic severity as assessed by the Hopkins Motor and Vocal Tic Scale (HM/VTS) [Within 1 week after completion of HRT]: Patient will nominate up to five motor and five vocal tics they deem bothersome on the HM/VTS. Each bothersome tic is then rated by a clinician on the composite two (vocal and motor) 5-point HM/VTS scale ranging from none (0) to severe (4) for the motor as well as vocal tics. The individual tic scores are summed (minimum of 0 and maximum of 40) and averaged together to create an average tic severity score.

Secondary outcomes

Tic severity as assessed by the Yale Global Tic Severity Scale-Revised (YGTSS) [Within 1 week after completion of HRT]: The YGTSS is a clinician-rated semi-structured interview that measures tic symptom severity over the previous week. It consists of 10-items that assess different dimensions of tic severity for motor and vocal tics, which are rated on a 0-5 scale. The YGTSS produces a Total Tic Score (range: 0-50), with higher ratings indicating greater tic severity. The YGTSS has demonstrated treatment sensitivity to pharmacotherapy and behavioral interventions.

+Eligibility

Sex: All, ages: 18 Years to 75 Years, accepts healthy volunteers

Inclusion Criteria:

* At least 18 years old,
* Have moderate tic severity or greater as evidenced by a YGTSS Total Tic Score greater than 13 (>9 for youth with motor or vocal tics only)
* Have not received more than 4 previous sessions of HRT
* Be fluent in English
* Medication free or on a stable dose of psychiatric medication for 8 weeks prior to enrollment.

Exclusion Criteria:

* An inability to complete rating scales
* An inability to attend study visits

+Locations (1)

Facility	City	Country	Status
Johns Hopkins University School of Medicine	Baltimore, Maryland	United States

+Investigators

Joseph F McGuire, PhD, Principal investigator, Johns Hopkins University

My Notes

Public

To Read Reading Read